The Japanese small-joint reconstructive implant market holds substantial growth potential due to its relatively lower penetration compared to more developed regions like the US and Europe. Going forward, market expansion will be fueled by favorable demographics. However, several factors may dampen this growth such as the slower introduction of high-priced devices in comparison to other mature global markets may influence overall growth. Additionally, downward pricing pressures driven by biennial reimbursement cuts could partially offset the impact of procedural expansion on market revenues.
This Medtech 360 Report provides comprehensive data and analysis on the state of the Japanese market for small-joint reconstructive implants from 2019 through 2032.
Which arthroplasty procedures showcased strong growth in 2022.
What factors are driving the growth in procedure volume and revenue?
Who are the leaders in the reconstructive shoulder implant market, and what are their upcoming innovations?
MNCs are the leading competitors in the market.
How are the leading competitors leveraging their market positions to maintain their shares?
What strategies are smaller competitors using to gain market share?
Which product segments should competitors focus on for growth opportunities?
Technological innovation will have a significant impact on the Japanese small-joint reconstructive implant market.
How will new products address unmet clinical needs, and how will the launch of these implants impact the market?